Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The IMQ-induced psoriasis mouse model was developed according to previously established methods
Regulatory bodies may require a dedicated cardiovascular outcomes trial before or after full approval is granted consistent with the precedent set for other agents in this class though the precise regulatory requirements will be determined by the MHRA and EMA based on the totality of evidence submitted
A two-unit error at 40 mg/mL changes your dose by 0.8 mg
doi: 10.1213/ANE.0000000000007921
US$ 26.65
US$ 22.42
US$ 25.75
US$ 22.82
US$ 22.87
